MD Anderson, Wiley To Host 2026 Cancer Neuroscience Event

Symposium will bring together experts from around the world to foster innovation in cancer research and patient care

HOBOKEN, NJ-The University of Texas MD Anderson Cancer Center's Cancer Neuroscience Program and Wiley's Advanced Portfolio will co-host the International Cancer Neuroscience Symposium Feb. 18-20, 2026 in Houston. The three-day hybrid event will take place at the Texas Medical Center Helix Park in the TMC3 Collaborative Building.

The symposium will bring together global experts in oncology, neuroscience, cancer biology, neuro-immunology and mental health with the goal of fostering innovation in cancer research and patient care through a unique integration of those disciplines.

This event will feature important insights and the latest cutting-edge research from more than 30 leading international experts, including Dr. James P. Allison (2018 Nobel Award winner in Physiology and Medicine), Dr. Sébastien Talbot, Dr. Douglas Hanahan and Dr. Erica Sloan.

"As cancer neuroscience rapidly reshapes our understanding of the disease, this symposium stands as a crucial gathering for the world's leading scientists, clinicians, and advocates," said Dr. Moran Amit, assistant professor in the Department of Head & Neck Surgery at MD Anderson and chair of the Cancer Neuroscience Symposium. "By unraveling how neural networks drive tumor growth, progression and metastasis, we ignite new hope for therapies that target cancer at its roots. We invite those interested to join us in 2026 to witness breakthroughs at the intersection of brain and biology-where collective innovation charts a bold path toward conquering cancer."

Multiple planned sessions will focus on neurobiology, neurotoxicity, neuroimmunology, neural neoplasms and neurobehavioral health encompassing the comprehensive spectrum of the growing field of cancer neuroscience. Two evening receptions are planned to provide even more opportunities for networking and collaboration discussions.

"Together with my co-directors Drs. Frederick Lang, Vinay Puduvalli and Jim Ray, we are proud to bring this pioneering symposium back to Houston," said Dr. Jian Hu, scientific director of the Cancer Neuroscience Program at MD Anderson. "Now in its third installment, the symposium is an opportunity to hear the latest research from the leaders in the emerging field of cancer neuroscience, which studies the many complex interactions between the nervous system and cancer, and to understand how these breakthroughs will be translated to improve patient outcomes".

MD Anderson's Cancer Neuroscience Program is a first-of-its-kind initiative that brings together the expertise of world-renowned neuroscientists and cancer researchers to study the two-way interaction between the nervous system and cancer. The program aims to use this knowledge to advance better treatments for patients with all types of cancer and to address patients' neurological and mental health challenges to improve their quality of life.

"We are proud to announce this partnership between the Advanced Portfolio and MD Anderson, which is doing such important work to accelerate innovation in cancer research and patient care," said Allyn Molina, Wiley group vice president, Publishing Development. "This symposium convenes global experts in oncology, neuroscience and cancer biology, underlining Wiley's commitment to bringing together diverse expertise to tackle complex challenges at the intersection of disciplines."

Wiley's Advanced Portfolio is a family of globally respected, high-impact journals that disseminates the best science from well-established and emerging researchers so they can fulfill their mission and maximize the reach of their scientific discoveries. The Advanced Portfolio is dedicated to cutting-edge research with tangible real-world applications.

Advanced Portfolio editors Ada Wong, Ph.D. and Monty Montano, Ph.D. will attend the symposium and will participate in a panel which continues the conversations they had with the symposium's key speakers in the CNS conversation series. These highly engaging and informational podcasts can be accessed here.

The symposium will feature daily poster presentations. Wiley will sponsor a special honor and award for abstracts selected for oral platform presentation.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.